BusinessWire
- Brent H. Zettl Provides Update on Holdings of ZYUS Life Sciences CorporationSASKATOON, Saskatchewan–(BUSINESS WIRE)–Mr. Brent H. Zettl (the “acquiror”), who serves as the President and CEO and a director of ZYUS… Read more »
- SINOVAC Board of Directors Prevails Against Advantech/Prime’s Lawsuit in Hong KongBEIJING–(BUSINESS WIRE)–The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical… Read more »
ZYUS Life Sciences Announces Closing of Unit OfferingSASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Corporation (the “Company”) (TSXV: ZYUS), a Canadian-based life sciences company focused on the development and… Read more »
Exicure, Inc. Reports First Quarter 2025 Financial ResultsREDWOOD CITY, Calif.–(BUSINESS WIRE)–Q1 2025 earnings release Read more »
Metabolics Pharma Announces ENT-03 Generates Sustained Weight Loss and Liver Pathology Improvements in an Animal Model for ObesityDOYLESTOWN, Pa.–(BUSINESS WIRE)–Metabolics Pharma Announces ENT-03 Generates Sustained Weight Loss and Liver Pathology Improvements in an Animal Model for Obesity Read more »
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD001TOKYO–(BUSINESS WIRE)–PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial… Read more »
Miraomics, Pythia Biosciences and LatchBio Release a 30 Million Cell Atlas and an Agentic AI Framework for Molecular Data CurationSAN FRANCISCO–(BUSINESS WIRE)–Miraomics, Pythia Biosciences and LatchBio released a 30 million cell atlas spanning over 150 indications, 200 tissue types… Read more »
Vetter Marks the Start of New Clinical Site Construction with Groundbreaking CeremonyRAVENSBURG, Germany & DES PLAINES, Ill.–(BUSINESS WIRE)–Vetter, a leading, globally operating Contract Development and Manufacturing Organization (CDMO), celebrated the start… Read more »
Ontrak Health Announces Pricing of $4 Million Public OfferingMIAMI–(BUSINESS WIRE)–Ontrak, Inc. (NASDAQ: OTRK), a leading value-based behavioral healthcare company powered by proprietary AI and engagement technology, today announced… Read more »
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research DiscoveriesVANCOUVER, British Columbia–(BUSINESS WIRE)–To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new… Read more »
Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström MacroglobulinemiaNEW YORK–(BUSINESS WIRE)–Schrödinger, Inc. (Nasdaq: SDGR) today announced that SGR-1505, its clinical stage MALT1 inhibitor, was designated as a Fast… Read more »
Bone Biologics Files Patent Application for Bone Regeneration TechnologyBURLINGTON, Mass.–(BUSINESS WIRE)—- $BBLG #Bonebiologics–Bone Biologics files U.S. patent application for bone regeneration technology Read more »
U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy LabelsPRINCETON, N.J.–(BUSINESS WIRE)—- $BMY #Abecma–U.S. FDA Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s… Read more »
Bone Biologics Regains Compliance with Nasdaq Continued Listing RequirementsBURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine… Read more »
Devonian Health Group Reports Third Quarter 2025 Financial ResultsQUÉBEC CITY–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), today announced financial results for its… Read more »
Verasonics Announces Enhancements to the Vantage® NXT Research Ultrasound Platform Designed to Further Improve Capabilities in Ultrasound Research and Product DevelopmentKIRKLAND, Wash.–(BUSINESS WIRE)– #biomedicalengineering–Verasonics, Inc., the leader in research ultrasound, today announced the release of new systems and features for… Read more »
Orano Med Inaugurates Expansion of its U.S. Research and Development Center in TexasPARIS–(BUSINESS WIRE)–Orano Med, a pioneer in radioligand therapies in oncology, inaugurated the expansion of its R&D Center located in Plano,… Read more »
Master FDA Regulations: Comprehensive Guidance on Regulatory Compliance in Drug Development (2 Day Online Training Course: July 16-17, 2025) – ResearchAndMarkets.comDUBLIN–(BUSINESS WIRE)–The “FDA Regulatory Compliance for Drug and Biotech Products (ONLINE EVENT: July 16-17, 2025)” training has been added to… Read more »
ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV SeasonRAHWAY, N.J.–(BUSINESS WIRE)—- $MRK #MRK–ACIP Recommends Merck’s ENFLONSIA for Prevention of RSV in Infants Younger than 8 Months of Age… Read more »
Javelin Biotech Strengthens Board with Robin Robinson as Drug Discovery Shifts Towards Human-Based ModelsWOBURN, Mass.–(BUSINESS WIRE)–Javelin Biotech appointed Dr. Robin Robinson to its board, reinforcing human-centric drug discovery aligned with the FDA Modernization… Read more »
QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory BoardVENLO, Netherlands–(BUSINESS WIRE)—- $QGEN #QIAGEN–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its Supervisory Board has elected… Read more »
Carlsmed Announces Filing of Registration Statement for Proposed Initial Public OfferingCARLSBAD, Calif.–(BUSINESS WIRE)–Carlsmed, Inc. (“Carlsmed”), a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that it… Read more ».jpg)
Biocom California’s 2025 Economic Impact Report Highlights Importance of the State’s Life Science Industry — One of the Top Industries in the Fourth Largest Economy in the WorldSOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO–(BUSINESS WIRE)–Biocom California, the association representing the California life science industry,… Read more »
TheracosBio Collaborates with Publix Pharmacy to Provide Affordably Priced FDA-approved Diabetes MedicationFRAMINGHAM, Mass.–(BUSINESS WIRE)–TheracosBio today announced that BRENZAVVY® (bexagliflozin), an FDA-approved oral sodium-glucose cotransporter 2 (SGLT2) inhibitor for the treatment of… Read more »
FUJIFILM VisualSonics Launches the Vevo F2 LAZR-X20 Photoacoustic Imaging Platform for Preclinical UltrasoundTORONTO–(BUSINESS WIRE)–FUJIFILM VisualSonics Inc., a world leader in ultra-high frequency ultrasound and photoacoustic imaging systems, today announced the availability of… Read more »
Alcon Canada Earns Global Recognition as a Top EmployerTORONTO–(BUSINESS WIRE)– #AlconCanada–Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that Alcon Canada… Read more »
OQP BioM Shareholder Alliance: Quest-pharma Tech's Takeover Bid for OQP BioM Faces Scrutiny Amid Accusations and SilenceYONGIN, South Korea–(BUSINESS WIRE)– #Investor–OQP BioM Shareholder Alliance (represented by Jung-Woo Bae) has voiced criticism against Dr. Madiyalakan’s refusal to… Read more »- Iambic Taps Lambda for Increased AI Compute as it Develops the Next Generation of Enchant, a Breakthrough AI Molecular Property Prediction Model for Drug DiscoverySAN JOSE, Calif.–(BUSINESS WIRE)–Lambda, the GPU cloud company founded by AI engineers, today announced that Iambic Therapeutics, a clinical-stage life… Read more »
bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics ConferenceSAN ANTONIO–(BUSINESS WIRE)– #BIAF–bioAffinity scientists present breakthrough research on using siRNAs to knock down two receptors on the cell membrane… Read more »
Ephicacy Appoints Névine Zariffa to Its Board of DirectorsISELIN, N.J.–(BUSINESS WIRE)–Ephicacy Consulting Group, Inc. has announced the addition of Névine Zariffa to the board. Read more »
A2 Bio Announces First Patient Dosed in DENALI-1 Phase 1/2 Clinical Study of A2B395, a Novel Allogeneic Precision CAR T Cell Therapy for Patients with Solid Tumors that Express EGFRAGOURA HILLS, Calif.–(BUSINESS WIRE)– #CellTherapy–A2 Bio doses first patient in the DENALI-1 clinical study of A2B395, an allogeneic logic-gated CAR… Read more »- Aditxt to Present at Wall Street Reporter’s NEXT SUPER STOCK Livestream Today June 26, 2025, at 1 p.m. ETMOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, is… Read more »
CDR-Life Announces CDR609 as New T-Cell Engager Clinical Candidate Targeting LGR5, a Highly Cancer-specific Surface Antigen Widely Expressed on Common Solid TumorZURICH–(BUSINESS WIRE)–CDR-Life Inc., a biotechnology company developing highly selective T cell engagers (TCEs) to treat cancer and autoimmune diseases, today… Read more »
Alto Neuroscience Identifies Biomarker and Reports Positive Pharmacodynamic Results from Exploratory Phase 2 Proof-of-Concept Trial of ALTO-203MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)—- $ANRO #PrecisionPsychiatry–Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of… Read more »
Incyte Appoints Bill Meury Chief Executive Officer; Hervé Hoppenot to RetireWILMINGTON, Del.–(BUSINESS WIRE)—- $INCY–Incyte Appoints Bill Meury Chief Executive Officer; Hervé Hoppenot to Retire Read more »
KalVista Pharmaceuticals Enters into Licensing Agreement with Pendopharm to Commercialize Sebetralstat for HAE in CanadaCAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that its wholly-owned subsidiary, KalVista Pharmaceuticals, Ltd., has… Read more »- Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter from the U.S. Food and Drug Administration for ADX-2191 for the Treatment of Primary Vitreoretinal LymphomaLEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced receipt of a Special Protocol Assessment Agreement Letter from the… Read more »
Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with InhibitorsNEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 BASIS study (NCT03938792) evaluating HYMPAVZI™… Read more »
BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D DaySAN CARLOS, Calif.–(BUSINESS WIRE)—- $ONC #BeOne–In a significant showcase for investors, BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235),… Read more »
IFF Launches Transformational Culture to Drive Energy and Water Efficiency in Semi-Hard Cheese ProductionLEIDEN, Netherlands–(BUSINESS WIRE)–IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health, and biosciences—announced the launch of CHOOZIT® LIFT,… Read more »
PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private PlacementBOSTON–(BUSINESS WIRE)–PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset & $175M Private… Read more »
GenSight Biologics Announces Significant Milestone in New Manufacturing Partnership with CatalentPARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative… Read more »- Avvio Medical Proudly Announces ISO 13485 Certification, Marking a Major Milestone in Global MedTech ReadinessSAN FRANCISCO–(BUSINESS WIRE)–Avvio Medical, Inc., a clinical-stage medical device company focused on transforming the treatment of kidney stone disease, is… Read more »
AGC Biologics Expands Cell Therapy Development Operations to Asia to Serve Growing Market NeedTOKYO–(BUSINESS WIRE)–AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1 at AGC Inc.’s Yokohama… Read more »